Aclaris Therapeutics (GB:0H8T)
LSE:0H8T
Holding GB:0H8T?
Track your performance easily

Aclaris Therapeutics (0H8T) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Strong Sell
2Bullish
1Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Aclaris Therapeutics’s (0H8T) Moving Averages Convergence Divergence (MACD) indicator is 0.35, suggesting Aclaris Therapeutics is a Sell.
Aclaris Therapeutics’s (0H8T) 20-Day exponential moving average is 2.01, while Aclaris Therapeutics’s (0H8T) share price is $2.643, making it a Buy.
Aclaris Therapeutics’s (0H8T) 50-Day exponential moving average is 1.62, while Aclaris Therapeutics’s (0H8T) share price is $2.643, making it a Buy.

Aclaris Therapeutics (0H8T) Pivot Points

Nov 14, 2024, 06:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.18
2.28
2.38
2.48
2.58
2.68
2.78
Fibonacci
2.28
2.36
2.41
2.48
2.56
2.60
2.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (0H8T) Moving Averages

Nov 14, 2024, 06:14 AM
Period
Simple
Exponential
MA5
2.52Buy
2.49Buy
MA10
2.32Buy
2.30Buy
MA20
1.86Buy
2.01Buy
MA50
1.45Buy
1.62Buy
MA100
1.35Buy
1.43Buy
MA200
1.27Buy
1.30Buy
Aclaris Therapeutics’s (0H8T) 10-Day exponential moving average is 2.30, while Aclaris Therapeutics’s (0H8T) share price is $2.643, making it a Buy.
Aclaris Therapeutics’s (0H8T) 100-Day exponential moving average is 1.43, while Aclaris Therapeutics’s (0H8T) share price is $2.643, making it a Buy.
Aclaris Therapeutics’s (0H8T) stock price is $2.643 and Aclaris Therapeutics’s (0H8T) 50-day simple moving average is 1.45, creating a Buy signal.
Aclaris Therapeutics’s (0H8T) stock price is $2.643 and Aclaris Therapeutics’s (0H8T) 100-day simple moving average is 1.35, creating a Buy signal.
Aclaris Therapeutics’s (0H8T) stock price is $2.643 and Aclaris Therapeutics’s (0H8T) 200-day simple moving average is 1.27, creating a Buy signal.

Aclaris Therapeutics (0H8T) Technical Indicators

Nov 14, 2024, 06:14 AM
Name
Value
Implied Action
RSI (14)
81.20
Sell
STOCH (9,6)
81.62
Sell
STOCHRSI (14)
87.44
Sell
MACD (12,26)
0.35
Sell
ADX (14)
52.89
Sell
Williams %R
-2.64
Sell
CCI (14)
112.67
Sell
ATR (14)
0.15
-
Ultimate Oscillator
68.50
Neutral
ROC
107.78
Buy
Aclaris Therapeutics’s (0H8T) Relative Strength Index (RSI) is 81.20, creating a Sell signal.
Aclaris Therapeutics’s (0H8T) Trend Strength Indicator (ADX) is 52.89, creating a Sell signal.
Aclaris Therapeutics’s (0H8T) Commodity Channel Index (CCI) is 112.67, creating a Sell signal.
Aclaris Therapeutics’s (0H8T) Price Rate of Change (ROC) is 107.78, creating a Buy signal.

FAQ

Is 0H8T a Buy, Hold, or Sell?
Based on 0H8T’s technical indicators, 0H8T is a Buy.
    What is 0H8T’s RSI (14)?
    0H8T’s RSI (14) is 81.20, which suggests 0H8T is a Sell.
      What is 0H8T’s MACD?
      0H8T’s MACD is 0.35, which suggests 0H8T is a Sell.
        What is 0H8T’s 5-day moving average?
        0H8T’s 5-day moving average is 2.52, which suggests 0H8T is a Buy.
          What is 0H8T’s 20-day moving average?
          0H8T 20-day moving average is 1.86, which suggests 0H8T is a Buy.
            What is 0H8T’s 50-day moving average?
            0H8T’s 50-day moving average is 1.45, which suggests 0H8T is a Buy.
              What is 0H8T’s 200-day moving average?
              0H8T’s 200-day moving average is 1.27, which suggests 0H8T is a Buy.
                What is 0H8T’s Williams % R (14)?
                0H8T’s Williams % R (14) is -2.64, which suggests 0H8T is a Sell.
                  What is 0H8T’s CCI (14)?
                  0H8T’s CCI (14) is 112.67, which suggests 0H8T is a Sell.
                    What is the share price of Aclaris Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis